Clinical and pathological analysis of companion diagnostic testing of microsatellite instability-high for pembrolizumab in gynaecologic malignancy

Medicine & Life Sciences

• pembrolizumab 100%
• Microsatellite Instability 87%
• Endometrial Neoplasms 48%
• Hereditary Nonpolyposis Colorectal Neoplasms 41%
• Neoplasms 22%
• Ovarian Neoplasms 21%
• Uterine Cervical Neoplasms 14%
• Genetic Counseling 8%
• Genetic Testing 8%
• Health Care Outcome Assessment 5%
• Biomarkers 5%